Jamie le
Family Medicine · Richardson, TXNPI 1073104576
Payments from drug & device makers
Across 274 payments — averaging $33.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Bayer$1K
- Amgen$920
- Gilead$896
- Novo Nordisk$881
- AbbVie$767
- plus $3K from 27 others
What the payments were for
- Food & beverage$9,051100%
- Education$100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 27 | $1,476 |
| Bayer | 43 | $1,206 |
| Amgen | 23 | $920 |
| Gilead | 13 | $896 |
| Novo Nordisk | 33 | $881 |
| AbbVie | 29 | $767 |
| Boehringer Ingelheim | 26 | $519 |
| GSK | 14 | $480 |
| Lilly USA, LLC | 13 | $404 |
| Merck | 7 | $209 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $189 |
| Corcept Therapeutics | 5 | $175 |
| Optinose US, Inc. | 2 | $143 |
| Kowa Pharmaceuticals America, Inc. | 3 | $138 |
| Axsome Therapeutics, Inc. | 1 | $120 |
| Renalytix AI, Inc. | 6 | $92 |
| Amarin Pharma, Inc. | 4 | $57 |
| Pfizer | 3 | $51 |
| Biohaven Pharmaceuticals, Inc. | 1 | $50 |
| Novartis | 2 | $37 |
| Exact Sciences | 1 | $30 |
| Dexcom, Inc. | 2 | $27 |
| Johnson & Johnson | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Avanir Pharmaceuticals, Inc. | 1 | $19 |
| Tanabe Pharma America, Inc. | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
| Abbott | 1 | $16 |
| Seqirus USA Inc | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Acorda Therapeutics, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,060 in reported general payments places this provider in the 90th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 102 | $142,867 |
| JardianceEmpagliflozin | 26 | $39,887 |
| JanuviaSitagliptin Phosphate | 16 | $24,816 |
| VascepaIcosapent Ethyl | 15 | $16,393 |
| Omega-3 Acid Ethyl Esters | 25 | $5,649 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 16 | $3,756 |
| Fluticasone Propionate | 43 | $1,114 |
| Losartan Potassium | 121 | $957 |
| Atorvastatin Calcium | 127 | $840 |
| Diclofenac Sodium | 32 | $792 |
| Levocetirizine Dihydrochloride | 53 | $792 |
| Tamsulosin Hcl | 36 | $500 |
| Memantine Hcl | 13 | $469 |
| Gabapentin | 24 | $444 |
| Omeprazole | 12 | $361 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $1,476 | $142,867102 claims |
| Boehringer IngelheimJardiance | $519 | $39,88726 claims |
| MerckJanuvia | $209 | $24,81616 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Richardson
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.